CN1850253A - Qianjin-Baoyun preparation and novel preparing method - Google Patents
Qianjin-Baoyun preparation and novel preparing method Download PDFInfo
- Publication number
- CN1850253A CN1850253A CNA2006100572773A CN200610057277A CN1850253A CN 1850253 A CN1850253 A CN 1850253A CN A2006100572773 A CNA2006100572773 A CN A2006100572773A CN 200610057277 A CN200610057277 A CN 200610057277A CN 1850253 A CN1850253 A CN 1850253A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- radix
- active component
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to Chinese medicine composition for curing threatened abortion with vaginal bleeding, lumbago during pregnancy and preventing habitual abortion and its preparation process. Said Chinese medicine composition can be made into dripping pills and soft capsule preparation.
Description
Technical field:
The present invention relates to a kind of Chinese medicine composition and preparation technology thereof, particularly a kind of fetal movement leakage blood, lumbago during pregnancy, the prescription of prevention of miscarriage and preparation technology thereof of being used for.
Background technology:
Blood is leaked in fetal movement, and lumbago during pregnancy is clinically to see that symptom, the traditional Chinese medical science often take the means of nourishing blood and preventing abortion that it is treated more, and evident in efficacy.The Qianjin-Baoyun ball is that it represents medicine.But in the practice, because this medicine is medical material to be beaten powder be used as medicine in preparation, cause impurity many, shortcoming such as dosage is big has a strong impact on its clinical practice.
The preparation of process extraction process preparation of the present invention is easy to dissolving and absorption than elite and thick putting that ordinary pill more can collect medicine, and curative effect is fast, and administration time is short, and therefore, curative effect is better.
The purpose of this invention is to provide a kind of therapeutic domain wide, easily accept, easily absorb, the preparation technology of efficient, low dosage, the Chinese medicine dripping pills that has no side effect, soft capsule, granule, chewable tablet, its pill that makes can be used for curing mainly fetal movement and leaks blood, lumbago during pregnancy, prevention of miscarriage.
Summary of the invention:
The present invention relates to a kind of prescription and preparation technology thereof of Chinese medicine preparation, it is characterized in that, the preparation of per 1000 dosage units is prepared from by following proportion raw material:
50～200 parts of 50～200 parts of Semen Cuscutae of 50～200 parts of Rhizoma Atractylodis Macrocephalaes of the Cortex Eucommiae (parching to brown)
25～100 parts of 25～100 parts of Radix Dipsacis of 35～140 parts of Radix Angelicae Sinensis of Radix Rehmanniae Preparata
12.5～50 parts of Radix Scutellariae (processed with wine) 25～100 parts of Radixs Astragali of 25～100 parts of Cortex Magnoliae Officinalis (system)
12.5～50 parts in 12.5～50 parts of Colla Corii Asini of 12.5～50 parts of Pericarpium Citri Reticulataes of Rhizoma Chuanxiong
7.5～30 parts of 20 parts of Fructus Aurantiis of 12.5～50 portions of Radix Paeoniae Albas of Folium Artemisiae Argyi (charcoal) (wine stir-fry)
7.5～30 parts in Fructus Amomi 7.5～30 portions of Radix Glycyrrhizaes of 7.5～30 parts of Bulbus Fritillariae Cirrhosaes (system).
Preferably:
100 parts of 100 parts of Semen Cuscutae of 100 parts of Rhizoma Atractylodis Macrocephalaes of the Cortex Eucommiae (parching to brown)
50 parts of 50 parts of Radix Dipsacis of 70 parts of Radix Angelicae Sinensis of Radix Rehmanniae Preparata
25 parts of Radix Scutellariae (processed with wine) 50 parts of Radixs Astragali of 50 parts of Cortex Magnoliae Officinalis (system)
25 parts in 25 parts of Colla Corii Asini of 25 parts of Pericarpium Citri Reticulataes of Rhizoma Chuanxiong
15 parts of 20 parts of Fructus Aurantiis of 25 portions of Radix Paeoniae Albas of Folium Artemisiae Argyi (charcoal) (wine stir-fry)
15 parts in Fructus Amomi 15 portions of Radix Glycyrrhizaes of 15 parts of Bulbus Fritillariae Cirrhosaes (system).
In more than forming, the weight of medicine is calculated with crude drug, and per 1 part can be 1 gram, also can be kilogram or ton, if be unit with gram, this prescription composition can be made into 1000 doses of pharmaceutical preparatioies.Described 1000 doses of fingers, the final drug preparation of making, as make 1000 of soft capsule preparations, drop pill 1000 balls, granule 1000g etc., also can make big packing as granule, as 100～500 bags, specifically can be 100 bags, 125 bags, 200 bags, 250 bags, 500 bags etc., every bag can be used as taking dose 1 time.
More than form, can be made into the preparation of 50～1000 taking doses,, make 125 bags, take 1～2 bag at every turn, can take altogether 62.5～125 times as granule.
More than form to be by weight as proportioning, when producing, can increase or reduce according to corresponding proportion, as large-scale production can be unit with the kilogram, or be unit with the ton, small-scale production can be unit with the milligram also, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
The raw material of Chinese medicine of said ratio extracts processing through new technology of the present invention, obtain the active constituents of medicine of preparation of the present invention, add suitable excipient as required and make suitable medicinal any dosage form, said preparation can be drop pill, capsule, granule, tablet, mixture, fluid extract and extractum, soft extract, powder.
The above new technology of the present invention may further comprise the steps:
Method a:(technology 1.)
(1) gets the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Fructus Aurantii medical material, adopt steam distillation (or supercritical extraction): medical material is shredded, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 6～12 with the water ratio, and oil is 1: 4～12 with β-CD ratio, and ultrasonic 30～70min gets clathrate;
(2) get the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials, decoct with water 2～5 times, each 0.5～3 hour, collecting decoction filtered, and it is standby that filtrate is condensed into thick extractum;
(3) directly be used as medicine after the Colla Corii Asini molten;
(4) get the residue medical material, soaked 30～90 minutes earlier with 50～95% ethanol, reheat reflux, extract, 2～6 times, each 0.5～3 hour, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby.
Above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) getting the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials beats powder and is used as medicine;
(2) prescription residue medical material is handled the same;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as tablet of the present invention and capsule.
The active constituents of medicine of the preparation of the present invention that above method obtains can be prepared into preparation of the present invention through further processing.
Preparation of the present invention, different dosage form method difference below is the preparation method of several preferred dosage form.
(1) preparation of drop pill
Drop pill of the present invention, wherein the ratio of active component and adjuvant is 1: 0.5～10, and preferred ratio is 1: 2～4, and most preferred ratio is 1: 3.The above adjuvant be specially molecular weight polyethylene glycol between 400 to 10000 Polyethylene Glycol and their mixture, as PEG400 (PEG400), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture or other suitable other auxiliary elements of making drop pill, as glycerol, gelatin or stearic acid sodium etc.
Following steps are taked in the preparation of drop pill of the present invention:
1. be ready to following raw material: active component, adjuvant and/or other inactive ingredients;
2. with the above-mentioned raw materials mix homogeneously;
3. add the transconversion into heat material, move into the drip irrigation of drop pill machine, medicinal liquid splashes in the liquid sub liquid paraffin by water dropper, removes liquid paraffin, selects ball, promptly.
(2) preparation of soft capsule
Soft capsule preparation of the present invention is that active component and pharmaceutically useful organic solvent and the material of making soft capsule shell are formed.Organic solvent wherein is selected from PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, the material of wherein making soft capsule shell is gelatin or arabic gum, water, plasticizer and antiseptic, the weight ratio of gelatin or arabic gum and plasticizer is 1.0: 0.4～1.0 in the soft capsule shell, and the weight ratio of gelatin and water is 1.0: 0.8～1.2; The content of active component is 50mg～500mg in every soft capsule.
The preparation method of preparation of the present invention, the process following steps:
A. get gelatin, glycerol, pure water adds thermosol, adds an amount of antiseptic, preparation rubber;
B. get active component and be dissolved in organic solvent, add suitable quantity of water, be prepared into soft capsule through encapsulating machine.
(3) preparation process of granule is as follows: with the gained active component, add a certain amount of correctives, filler, lubricant, granulate, promptly get granule.
(4) preparation method of chewable tablet is as follows: with the gained active component, add a certain amount of correctives, filler, lubricant, granulate, and drying, tabletting promptly gets chewable tablet.
Filler described in the preparation of granule, chewable tablet is selected from one or more the mixture in lactose, sucrose, dextrin, starch, microcrystalline Cellulose, mannitol, pregelatinized Starch, sorbitol, the xylitol etc.;
Described correctives one of is selected from Rhizoma et radix valerianae, Fructus Pruni pseudocerasi, Fructus Vitis viniferae, Fructus Citri tangerinae, Fructus Citri Limoniae, Herba Menthae, Fructus Fragariae Ananssae, Fructus Musae, Fructus Ananadis comosi, honey peach essence, maltose alcohol, saccharin sodium, protein sugar, sucrose, aspartame, the stevioside or wherein several mixture;
Suitable lubricant comprises wherein one or more such as magnesium stearate, Pulvis Talci, micropowder silica gel.
Following data declaration beneficial effect of the present invention by experiment:
In order to prove the Clinical feasibility that changes after the technology, we have carried out its main pharmacodynamics, toxicologic study to this medicine, observe its therapeutical effect, and the clinical experimental basis that provides is provided.
1, to the influence of young female mouse vagina superficial cell
Get 40 of body weight 29.53 ± 2.65g female mices, be divided into four groups at random, i.e. the normal saline group, estradiol group (0.03ml/ is only), technology is extractum group (0.15g/kg) 1., and technology is extractum group (0.2g/kg) 2., administering mode is for irritating stomach, and successive administration seven days the results are shown in Table 1.
The influence of table 1 pair young female mice superficial cell (x ± s)
| Group | The epithelial influence of keratinization after the administration/ | ||||||
| The 1st day | The 2nd day | The 3rd day | The 4th day | The 5th day | The 6th day | The 7th day | |
| Normal saline group estradiol group technology is 2. extractum group of extractum group technology 1. | 1.70±1.25 55.30±0.71 33.50±22.29 41.40±19.86 | 1.20±0.79 65.40±11.63 56.90±31.55 50.30±19.20 | 2.10±1.66 94.96±8.06 76.30±26.12 51.40±20.06 | 1.40±1.26 92.10±6.76 71.20±24.93 62.40±16.30 | 1.20±092 97.10±2.79 52.90±28.15 35.60±12.04 | 1.40±1.07 90.00±13.19 50.10±26.94 38.30±13.26 | 2.50±1.23 81.60±20.89 50.60±27.78 45.00±19.10 |
The result shows, mirror is observed down behind the animal via vaginal smear, normal saline control animals superficial cell number is less, the more estradiol group of leukocyte, two extractum groups, the vaginal smear mirror shows that down a large amount of superficial cells generate, each group more all has significant difference (P＜0.01) with the normal saline matched group, and prompting extractum group has the effect that improves young female mice body inner estrogen level.
2, to the influence of mouse uterine weight
Grouping, dosage and medication are with 1, each treated animal all the last time after the administration 24h put to death with the cervical vertebra dislocation, back of the body position is fixing, open the abdominal cavity, take out whole uterus and be laid in the plate, carefully remove fatty tissue and ovary around the uterus by shape in the body, at scales/electronic balance weighing, be converted into the per kilogram of body weight uterus weight rapidly.The result shows, the estradiol group, technology is the extractum group 1., the technology 2. uterus weight of extractum group per kilogram of body weight is respectively: 6 6490 ± 1.0915g, 4.29320 ± 0.6323g, 4.1291 ± 0.963g, compare with matched group 2.6951 ± 0.3619g, utmost point significant difference (P＜0.01) is all arranged, show that each administration group all can increase uterus weight, points out this extractum can improve estrogenic level.
3, young female rat induced ovulation is reached the influence that corpus luteum is formed
The results are shown in Table 2.
Table 2 pair young female rat induced ovulation and influence that corpus luteum is formed (x ± s)
| Group | Number of animals (only) | Dosage (g/kg) | Number of eggs ovulated (individual) | Corpus luteum number (individual) |
| Normal saline group ovulation model group clomiphene group technology is 2. extractum group of extractum group technology 1. | 10 10 10 10 10 | - 15IUHCG 0.005 0.08 0.1 | 0 22.20±6.03 △△ 30.90±9.96 ** 33.20±10.00 ** 32.60±9.93 ** | 0 12.85±6.10 △△ 14.45±7.15 ** 10.60±4.61 ** 14.50±5.36 ** |
Annotate: model group and normal saline group compare,
△ △P＜0.01 administration group and matched group are relatively
*P＜0.05;
*P＜0.01
The result shows that the normal saline group is not seen ovulation, all has ovulation to take place by each treated animal of gastric infusion, and the extractum group more all has significant difference (P＜0.01) with the ovulation model group, shows that the extractum group has obvious ovulation effect to the young female rat.Normal saline matched group ovary is not seen corpus luteum under mirror, and each treated animal of administration all has corpus luteum to form, but there was no significant difference between each administration group points out this extractum that corpus luteum is formed no obvious dependency.
4, toxicological study
Acute toxicity test shows that rat oral gavage extract of the present invention fails to measure LD
50
Long term toxicity test: rat grouping, extract of the present invention is irritated stomach, every day three times, connect and annotate 90d, the result, administration group rat and control rats movable, search for food, drinking-water, body weight and multinomial observation indexs such as substantial viscera pathologic finding and histopathology detect, result of the test is not all found any toxicity; Hemogram and hepatic and renal function index and the equal no significant difference of matched group.
The blood vessel irritation of this medicine, allergy and hemolytic test all are negative.
In sum, preparation of the present invention, dropping pill formulation particularly of the present invention and soft capsule preparation are that blood, lumbago during pregnancy, the medicine of prevention of miscarriage are leaked in a kind of good treatment fetal movement, and change preparation technology, can obviously strengthen clinical efficacies such as its nourishing blood and preventing abortion, its hypotoxicity in addition, prolonged application safety, therefore, be worth clinical application.
The specific embodiment:
Further specify the present invention by the following examples, include but not limited to the following example.
Embodiment 1:
The preparation method of drop pill of the present invention:
Prescription:
The Cortex Eucommiae 80g Rhizoma Atractylodis Macrocephalae (parching to brown) 80g Semen Cuscutae 80g
Radix Rehmanniae Preparata 56g Radix Angelicae Sinensis 40g Radix Dipsaci 40g
Radix Scutellariae (processed with wine) the 40g Cortex Magnoliae Officinalis 40g Radix Astragali (system) 20g
Rhizoma Chuanxiong 20g Pericarpium Citri Reticulatae 20g Colla Corii Asini 20g
Folium Artemisiae Argyi (charcoal) the 20g Radix Paeoniae Alba (wine stir-fry) 16g Fructus Aurantii 9g
Fructus Amomi 9g Bulbus Fritillariae Cirrhosae 9g Radix Glycyrrhizae (system) 9g
PEG4000 100g
Make 1000 balls
Preparation method:
(1) gets the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Fructus Aurantii medical material, adopt steam distillation (or supercritical extraction): medical material is shredded, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 10 with the water ratio, and oil is 1: 6 with β-CD ratio, and ultrasonic 40min gets clathrate;
(2) get the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials, decoct with water 3 times, each 1 hour, collecting decoction filtered, and it is standby that filtrate is condensed into thick extractum;
(3) directly be used as medicine after the Colla Corii Asini molten;
(4) get the residue medical material, soaked 30 minutes earlier with 75% ethanol, reheat reflux, extract, 2 times, each 1.5 hours, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby.
(5) with above-mentioned extract obtained, the PEG4000 that adds recipe quantity puts into the vessel in heating dissolving, and jolting makes and dissolves into uniform solution, inserts in the fluid reservoir.Keep 80 ℃ the system of dripping temperature, and a control speed, condensed fluid is a liquid paraffin, drips system promptly.
Embodiment 2:
Preparation of soft capsule method of the present invention:
Prescription:
The Cortex Eucommiae 290g Rhizoma Atractylodis Macrocephalae (parching to brown) 290g Semen Cuscutae 100g
Radix Rehmanniae Preparata 203g Radix Angelicae Sinensis 145g Radix Dipsaci 145g
Radix Scutellariae (processed with wine) the 145g Cortex Magnoliae Officinalis 145g Radix Astragali (system) 72.5g
Rhizoma Chuanxiong 72.5g Pericarpium Citri Reticulatae 72.5g Colla Corii Asini 72.5g
Folium Artemisiae Argyi (charcoal) the 72.5g Radix Paeoniae Alba (wine stir-fry) 58g Fructus Aurantii 43.5g
Fructus Amomi 43.5g Bulbus Fritillariae Cirrhosae 43.5g Radix Glycyrrhizae (system) 43.5g
PEG400 430g
Make 1000
Preparation method:
(1) gets the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Fructus Aurantii medical material, adopt steam distillation (or supercritical extraction): medical material is shredded, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 10 with the water ratio, and oil is 1: 6 with β-CD ratio, and ultrasonic 40min gets clathrate;
(2) get the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials, decoct with water 3 times, each 1 hour, collecting decoction filtered, and it is standby that filtrate is condensed into thick extractum;
(3) directly be used as medicine after the Colla Corii Asini molten;
(4) get the residue medical material, soaked 30 minutes earlier with 75% ethanol, reheat reflux, extract, 2 times, each 1.5 hours, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby.
(5) with above-mentioned extract obtained, add an amount of PEG400 and mix and mixing, add the PEG400 of surplus then, promptly get medicinal liquid.It is standby in addition to join gelatin solution by certain prescription.The condition that control is suitable is regulated content weight, obtains soft capsule in the soft capsule machine.
Embodiment 3:
The preparation method of granule of the present invention:
Prescription:
The Cortex Eucommiae 400g Rhizoma Atractylodis Macrocephalae (parching to brown) 400g Semen Cuscutae 400g
Radix Rehmanniae Preparata 280g Radix Angelicae Sinensis 200g Radix Dipsaci 200g
Radix Scutellariae (processed with wine) the 200g Cortex Magnoliae Officinalis 200g Radix Astragali (system) 100g
Rhizoma Chuanxiong 100g Pericarpium Citri Reticulatae 25g Colla Corii Asini 100g
Folium Artemisiae Argyi (charcoal) the 100g Radix Paeoniae Alba (wine stir-fry) 80g Fructus Aurantii 60g
Fructus Amomi 60g Bulbus Fritillariae Cirrhosae 60g Radix Glycyrrhizae (system) 60g
Make 1000g
Preparation method:
(1) gets the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Fructus Aurantii medical material, adopt steam distillation (or supercritical extraction): medical material is shredded, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 10 with the water ratio, and oil is 1: 6 with β-CD ratio, and ultrasonic 40min gets clathrate;
(2) getting the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials beats powder and is used as medicine;
(3) directly be used as medicine after the Colla Corii Asini molten;
(4) get the residue medical material, soaked 30 minutes earlier with 75% ethanol, reheat reflux, extract, 2 times, each 1.5 hours, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby.
(5) above active component is merged, add aspartame 5.0g, dextrin 300.0g, granulate, drying sprays into essence 5.0g, promptly gets granule 1000g.
Embodiment 4:
The preparation method of chewable tablet of the present invention:
Prescription:
The Cortex Eucommiae 290g Rhizoma Atractylodis Macrocephalae (parching to brown) 290g Semen Cuscutae 100g
Radix Rehmanniae Preparata 203g Radix Angelicae Sinensis 145g Radix Dipsaci 145g
Radix Scutellariae (processed with wine) the 145g Cortex Magnoliae Officinalis 145g Radix Astragali (system) 72.5g
Rhizoma Chuanxiong 72.5g Pericarpium Citri Reticulatae 72.5g Colla Corii Asini 72.5g
Folium Artemisiae Argyi (charcoal) the 72.5g Radix Paeoniae Alba (wine stir-fry) 58g Fructus Aurantii 43.5g
Fructus Amomi 43.5g Bulbus Fritillariae Cirrhosae 43.5g Radix Glycyrrhizae (system) 43.5g
Make 1000
Preparation method:
(1) gets the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Fructus Aurantii medical material, adopt steam distillation (or supercritical extraction): medical material is shredded, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 10 with the water ratio, and oil is 1: 6 with β-CD ratio, and ultrasonic 40min gets clathrate;
(2) getting the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials beats powder and is used as medicine;
(3) directly be used as medicine after the Colla Corii Asini molten;
(4) get the residue medical material, soaked 30 minutes earlier with 75% ethanol, reheat reflux, extract, 2 times, each 1.5 hours, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby.
(5) above active component is merged, add aspartame 3.0g, mannitol 200.0g, granulation, drying adds magnesium stearate 3.0g, mixing, and tabletting promptly gets 1000 of chewable tablet.
Claims (10)
1, a kind of Chinese medicine preparation is characterized in that per 1000 dosage units are made by the following weight proportion raw material:
50～200 parts of 50～200 parts of Semen Cuscutae of 50～200 parts of Rhizoma Atractylodis Macrocephalaes of the Cortex Eucommiae (parching to brown)
25～100 parts of 25～100 parts of Radix Dipsacis of 35～140 parts of Radix Angelicae Sinensis of Radix Rehmanniae Preparata
12.5～50 parts of Radix Scutellariae (processed with wine) 25～100 parts of Radixs Astragali of 25～100 parts of Cortex Magnoliae Officinalis (system)
12.5～50 parts in 12.5～50 parts of Colla Corii Asini of 12.5～50 parts of Pericarpium Citri Reticulataes of Rhizoma Chuanxiong
7.5～30 parts of 20 parts of Fructus Aurantiis of 12.5～50 portions of Radix Paeoniae Albas of Folium Artemisiae Argyi (charcoal) (wine stir-fry)
7.5～30 parts in Fructus Amomi 7.5～30 portions of Radix Glycyrrhizaes of 7.5～30 parts of Bulbus Fritillariae Cirrhosaes (system).
2, the compound preparation of claim 1 is characterized in that, per 1000 dosage units are made by the following weight proportion raw material:
100 parts of 100 parts of Semen Cuscutae of 100 parts of Rhizoma Atractylodis Macrocephalaes of the Cortex Eucommiae (parching to brown)
50 parts of 50 parts of Radix Dipsacis of 70 parts of Radix Angelicae Sinensis of Radix Rehmanniae Preparata
25 parts of Radix Scutellariae (processed with wine) 50 parts of Radixs Astragali of 50 parts of Cortex Magnoliae Officinalis (system)
25 parts in 25 parts of Colla Corii Asini of 25 parts of Pericarpium Citri Reticulataes of Rhizoma Chuanxiong
15 parts of 20 parts of Fructus Aurantiis of 25 portions of Radix Paeoniae Albas of Folium Artemisiae Argyi (charcoal) (wine stir-fry)
15 parts in Fructus Amomi 15 portions of Radix Glycyrrhizaes of 15 parts of Bulbus Fritillariae Cirrhosaes (system).
3, claim 1 or any one Chinese medicine preparation of 2 are drop pill, capsule, granule, tablet, mixture, fluid extract and extractum, soft extract, powder.
4, the Chinese medicine preparation of claim 3 through described raw material is extracted processing, obtains active component, adds suitable adjuvant as required and makes.
5, the Chinese medicine preparation of claim 4 is characterized in that, described active component prepares through following steps:
Method a:(technology 1.)
(1) gets the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Fructus Aurantii medical material, adopt steam distillation (or supercritical extraction): medical material is shredded, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 6～12 with the water ratio, and oil is 1: 4～12 with β-CD ratio, and ultrasonic 30～70min gets clathrate;
(2) get the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials, decoct with water 2～5 times, each 0.5～3 hour, collecting decoction filtered, and it is standby that filtrate is condensed into thick extractum;
(3) directly be used as medicine after the Colla Corii Asini molten;
(4) get the residue medical material, soaked 30～90 minutes earlier with 50～95% ethanol, reheat reflux, extract, 2～6 times, each 0.5～3 hour, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby.
Above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) getting the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials beats powder and is used as medicine;
(2) prescription residue medical material is handled the same;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as tablet of the present invention and capsule.
6, the Chinese medicine preparation of claim 5 is characterized in that:
Described drop pill, wherein the ratio of active component and adjuvant is 1: 0.5～10, described adjuvant be molecular weight between 400 to 10000 Polyethylene Glycol and their mixture, be selected from PEG400 (or 600), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture.
Its preparation method is: active constituents of medicine and proper auxiliary materials behind 60～115 ℃ of mix homogeneously, are regulated the water dropper size with control drop pill weight, are that the coolant system of dripping forms with dimethicone or liquid paraffin, and coolant temperature is-10～5 ℃.
7, the Chinese medicine preparation of claim 5 is characterized in that:
Described soft capsule, its content is made up of active component and suitable substrate, and wherein the content of active component is 50mg～500mg in every soft capsule; Substrate wherein is selected from wherein one or more of PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, animal wet goods.
Its preparation method is: with active constituents of medicine and proper auxiliary materials mix homogeneously, obtain uniform suspension and/or solution, regulate content weight, compacting, dry getting final product.
8, the Chinese medicine preparation of claim 5 is characterized in that:
The preparation process of described granule is as follows: with above-mentioned extract obtained, add a certain amount of filler, correctives, lubricant, granulate, promptly get granule;
The preparation method of chewable tablet is as follows: with above-mentioned extract obtained, adds a certain amount of filler, correctives, lubricant, granulates, and drying, tabletting promptly gets chewable tablet.
9, the Chinese medicine preparation of claim 8 is characterized in that:
Described filler is selected from one or more the mixture in lactose, sucrose, dextrin, starch, microcrystalline Cellulose, mannitol, pregelatinized Starch, sorbitol, the xylitol etc.;
Described correctives one of is selected from Rhizoma et radix valerianae, Fructus Pruni pseudocerasi, Fructus Vitis viniferae, Fructus Citri tangerinae, Fructus Citri Limoniae, Herba Menthae, Fructus Fragariae Ananssae, Fructus Musae, Fructus Ananadis comosi, honey peach essence, maltose alcohol, saccharin sodium, protein sugar, sucrose, aspartame, the stevioside or wherein several mixture;
Suitable lubricant comprises wherein one or more such as magnesium stearate, Pulvis Talci, micropowder silica gel.
10, the preparation method of any one Chinese medicine preparation of claim 1～9 is characterized in that, the process following steps:
Described raw material of Chinese medicine is extracted processing, obtain active component, add suitable adjuvant and make; Wherein said active component prepares through following steps:
Method a:(technology 1.)
(1) gets the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Cortex Magnoliae Officinalis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Fructus Aurantii medical material, adopt steam distillation (or supercritical extraction): medical material is shredded, extract according to an appendix XD of pharmacopeia in 2005 essential oil extraction method, till no longer increasing to the volatile oil height; The volatile oil β-CDBao He, optimised process is: β-CD is 1: 6～12 with the water ratio, and oil is 1: 4～12 with β-CD ratio, and ultrasonic 30～70min gets clathrate;
(2) get the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials, decoct with water 2～5 times, each 0.5～3 hour, collecting decoction filtered, and it is standby that filtrate is condensed into thick extractum;
(3) directly be used as medicine after the Colla Corii Asini molten;
(4) get the residue medical material, soaked 30～90 minutes earlier with 50～95% ethanol, reheat reflux, extract, 2～6 times, each 0.5～3 hour, merge extractive liquid,, concentrating under reduced pressure becomes thick paste, and is standby.
Above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) getting the Radix Astragali, the Radix Paeoniae Alba, licorice medicinal materials beats powder and is used as medicine;
(2) prescription residue medical material is handled the same;
(3) above active component lumps together the active constituents of medicine into preparation of the present invention, and this active component is suitable for preparing various preparations such as tablet of the present invention and capsule.
Described drop pill, wherein the ratio of active component and adjuvant is 1: 0.5～10, described adjuvant be molecular weight between 400 to 10000 Polyethylene Glycol and their mixture, be selected from PEG400 (or 600), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture.
Its preparation method is: active constituents of medicine and proper auxiliary materials behind 60～115 ℃ of mix homogeneously, are regulated the water dropper size with control drop pill weight, are that the coolant system of dripping forms with dimethicone or liquid paraffin, and coolant temperature is-10～5 ℃.
Described soft capsule, its content is made up of active component and suitable substrate, and wherein the content of active component is 50mg～500mg in every soft capsule; Substrate wherein is selected from wherein one or more of PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, animal wet goods.
Its preparation method is: active constituents of medicine is mixed with proper auxiliary materials, obtain uniform suspension and/or solution, regulate content weight, compacting, dry getting final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2006100572773A CN1850253A (en) | 2006-03-10 | 2006-03-10 | Qianjin-Baoyun preparation and novel preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2006100572773A CN1850253A (en) | 2006-03-10 | 2006-03-10 | Qianjin-Baoyun preparation and novel preparing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1850253A true CN1850253A (en) | 2006-10-25 |
Family
ID=37131765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2006100572773A Pending CN1850253A (en) | 2006-03-10 | 2006-03-10 | Qianjin-Baoyun preparation and novel preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1850253A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101537159B (en) * | 2009-04-29 | 2011-02-02 | 赵翠英 | Traditional Chinese medicine composition and preparation method and application thereof |
| CN101647901B (en) * | 2009-04-16 | 2011-08-17 | 原枫 | Oral Chinese herba preparation for treating postpartum qi and blood deficiency of woman and production method thereof |
| CN102652767A (en) * | 2011-03-02 | 2012-09-05 | 华中科技大学 | Drug for promoting embryo implantation and preparation method thereof |
| CN103784850A (en) * | 2014-02-13 | 2014-05-14 | 刘世顺 | Chinese herbal medicine formula for treating habitual abortion and preparation method of Chinese herbal medicine |
-
2006
- 2006-03-10 CN CNA2006100572773A patent/CN1850253A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101647901B (en) * | 2009-04-16 | 2011-08-17 | 原枫 | Oral Chinese herba preparation for treating postpartum qi and blood deficiency of woman and production method thereof |
| CN101537159B (en) * | 2009-04-29 | 2011-02-02 | 赵翠英 | Traditional Chinese medicine composition and preparation method and application thereof |
| CN102652767A (en) * | 2011-03-02 | 2012-09-05 | 华中科技大学 | Drug for promoting embryo implantation and preparation method thereof |
| CN103784850A (en) * | 2014-02-13 | 2014-05-14 | 刘世顺 | Chinese herbal medicine formula for treating habitual abortion and preparation method of Chinese herbal medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1943610A (en) | Chinese medicine preparation for traumatic injury and blood stasis and swelling pain | |
| CN1824035A (en) | Swim bladder kidney nourishing preparation and its preparation method | |
| CN1775276A (en) | Fushu Preparation and new preparing method | |
| CN1824240A (en) | Shenshu Jianpi medicinal preparation for invigorating spleen and its new preparation method | |
| CN1748783A (en) | Dismenorrhea preparation and new preparing method | |
| CN1775279A (en) | Gynaecologic formulation and new preparing method | |
| CN1824101A (en) | Xingsuerchen medicinal preparation and its new preparation method | |
| CN1850253A (en) | Qianjin-Baoyun preparation and novel preparing method | |
| CN1775264A (en) | Maiwei-dihuang preparation and new preparing method | |
| CN1748748A (en) | Little leaf deervetch herb preparation for pregnant woman and new preparing method | |
| CN1823910A (en) | Joint pain preparation and its new preparation method | |
| CN1879799A (en) | Menstruation-regulating preparation with asiabell and cassia bark and method for preparing same | |
| CN1850264A (en) | Safflower preparation for treating wound and new preparing method | |
| CN1943690A (en) | A Chinese traditional medicinal composition with the curative effect of cleaning up of Stomach, intestine, effusing inner-heat/defecating | |
| CN1775258A (en) | Womb-warming pregnancy-aiding preparation and new preparing method | |
| CN1827159A (en) | Menstruation-regulating preparation and novel method for preparing the same | |
| CN1775243A (en) | Zhanhua hairy Antler formulation and new preparing method | |
| CN1943694A (en) | A Chinese traditional medicinal composition for treating renal deficiency, edema, lumbago and gonalgia, etc. | |
| CN1824109A (en) | Liaoyuanqili medicinal preparation and its new preparation method | |
| CN1824241A (en) | Medicinal preparation and its new preparation method | |
| CN1748741A (en) | Little leaf deervetch herb acne removing preparation and new preparing method | |
| CN1748764A (en) | Menstruation regulating and pregnancy promoting preparation and new preparing method | |
| CN1824128A (en) | Semen locking medicinal preparation and its new preparation method | |
| CN1823978A (en) | Hemorrhoid blood stopping agent and its preparation method | |
| CN1857662A (en) | Miscarriage preventing preparation and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |